|1.||Maksimova, M Iu: 2 articles (01/2013 - 01/2011)|
|2.||Morozova, E M: 2 articles (01/2013 - 01/2011)|
|3.||Vodop'ianov, N P: 2 articles (01/2013 - 01/2011)|
|4.||Pustokhanova, L V: 2 articles (01/2013 - 01/2011)|
|5.||Gaintseva, V D: 2 articles (07/2001 - 01/2000)|
|6.||Kolykhalov, I V: 2 articles (07/2001 - 01/2000)|
|7.||Pal'mina, N P: 2 articles (07/2001 - 01/2000)|
|8.||Burlakova, E B: 2 articles (07/2001 - 01/2000)|
|9.||Gavrilova, S I: 2 articles (07/2001 - 01/2000)|
|10.||Selezneva, N D: 2 articles (07/2001 - 01/2000)|
|1.||Alzheimer Disease (Alzheimer's Disease)
01/01/1993 - "The effectiveness of amiridin in senile dementia of the Alzheimer's type."
01/01/1991 - "[Effectiveness of amiridin in senile dementia of the Alzheimer type]."
04/01/1998 - "Thus, a previous study together with this investigation indicate that ipidacrine improves amnesia which consists of the impairment of the working and reference memory in various animal models, suggesting that ipidacrine is a useful candidate for the therapy of patients with Alzheimer's disease."
04/01/1992 - "[Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on synaptosomal uptake of neuromediators]."
07/01/2001 - "Acetylcholinesterase (ACE) activity and lipid peroxidation (LPO) parameters were measured in the blood of patients with Alzheimer's disease (AD) during treatment with amiridine and gliatiline. "
01/01/2011 - "[Neuromidin in mixed vascular and Alzheimer's dementia]."
01/01/2011 - "The efficacy of neuromidin (ipidacrinum), a nonselective inhibitor of acetylcholinesterase and butyrilcholinesterase was studied in patients with mixed vascular and Alzheimer's dementia of mild and moderate severity. "
01/01/1999 - "The paper presents a study concerning an influence of cerebrolysin on the efficiency of subsequent therapy with amiridin in patients with mild and moderate dementia of Altzheimer's type (DAT). "
01/01/2014 - "In this connection, the efficacy of acetylcholinesterase inhibitors: galantamine (reminil),neuromidin, rivastigmine in the treatment of PD patients with dementia is discussed. "
01/01/2011 - "Efficacy of neuromidin was studied in 62 patients with a small ischemic stroke and cognitive disorders. "
01/01/2010 - "The efficacy of neuromidin in the early rehabilitation of patients with a stroke is shown."
01/01/2013 - "Examination was carried out a month after the stroke and after 2 months of therapy with neuromidin (ipidacrinum). "
01/01/2013 - "[Neuromidin in the treatment of cognitive impairment in the early rehabilitation period of ischemic stroke]."
01/01/2013 - "[Neuromidin in the restoration of motor functions after ischemic stroke]."
|4.||Mononeuropathies (Mononeuritis Multiplex)
01/01/2015 - "[A clinical-electroneuromyographic study of the efficacy of ipidacrine in patients with mononeuropathies]."
01/01/2015 - "To evaluate the efficacy and tolerability of axamon (ipidacrine) therapy in patients with focal neuropathies--mononeuropathies. "
01/01/2012 - "[The use of ipidacrinum (neuromidin) in mononeuropathies]."
01/01/1998 - "Rheumatic patients presented affections of the peripheral and central venous systems, vegetative dysfunction, disturbed higher nervous activity manifesting as polyneuropathy, mononeuropathy, pyramid syndrome, dystonia, hypothalamic syndrome, reduced adaptive ability, low tonicity of the sympathetic nervous system, terminal branches of the motor axons, etc. Therapy of nervous disorders in rheumatic patients comprises treatment of cerebral circulation (vascular, nootropic drugs, cerebrolysin), asthenic, neurotic and vegetative disorders (sedative and vegetotropic drugs, etimisol, adaptogens), abnormalities of peripheral nervous system (amiridin, anticholinesterase preparations, vitamins B and others). "
|5.||Memory Disorders (Memory Loss)
05/01/1995 - "[The effect of amiridine and tacrine on reversible capture of neuromediators in experimental memory disorders]."
04/01/1992 - "The study of the drugs effective in the treatment of cognitive deficits and memory loss associated with senile dementia of the Alzheimer's type--tacrine and amiridin, acetylcholinesterase inhibitor physostigmine and nootrop piracetam on uptake of 3H-serotonin (3H-5-HT), 3H-adrenaline (3H-AD), 3H-noradrenaline (3H-HA), 2H-dopamine (3H-DA), 3H-gamma-aminobutyric acid (3H-GABA), 3H-glutamic acid (3H-GLU), 3H-aspartic acid (3H-ASP) and 3H-glycine (3H-GLI) showed that tacrine and amiridin (5 x 10(-5) M) statistically significantly (P less than 0.05) inhibited the uptake of 3H-DA and 3H-5-HT. "
|10.||Cholinergic Agents (Cholinergics)